Review decisions
Showing 50 results of 359 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1741871370149
Product Type: Drug
Control Number: 281754
DIN(s): 02555441
Manufacturer: Hikma Canada Limited
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-12-04
Decision / Authorization Date: 2025-02-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1739369525149
Product Type: Drug
Control Number: 280386
DIN(s): 02552507
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-10-26
Decision / Authorization Date: 2024-10-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1750275341752
Product Type: Drug
Control Number: 279583
DIN(s): 02493012
Manufacturer: Bausch Health Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-10-03
Decision / Authorization Date: 2024-12-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1742225785828
Product Type: Drug
Control Number: 280730
DIN(s): 02554151
Manufacturer: Xediton Pharmaceuticals Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-11-03
Decision / Authorization Date: 2024-12-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1747928612535
Product Type: Drug
Control Number: 262828
DIN(s): 02323273
Manufacturer: Galderma Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-28
Decision / Authorization Date: 2023-02-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1747930145493
Product Type: Drug
Control Number: 267413
DIN(s): 02451034, 02459930, 02459949
Manufacturer: Amgen Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-08-29
Decision / Authorization Date: 2023-07-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1738608725112
Product Type: Drug
Control Number: 282097
DIN(s): 02468816
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-12-14
Decision / Authorization Date: 2025-01-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1747926145388
Product Type: Drug
Control Number: 270381
DIN(s): 02409607, 02409615, 02540053
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2022-12-05
Decision / Authorization Date: 2023-07-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1743436509830
Product Type: Drug
Control Number: 262779
DIN(s): 02473569
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-24
Decision / Authorization Date: 2023-02-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1749230174238
Product Type: Drug
Control Number: 270609
DIN(s): 02528908
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2022-12-13
Decision / Authorization Date: 2023-07-11